Mitsuhiro Sato
Operationeel Directeur bij Fujifilm Kyowa Kirin Biologics Co., Ltd.
Oorsprong van het eerstegraads netwerk van Mitsuhiro Sato
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
Centus Biotherapeutics Ltd.
 Centus Biotherapeutics Ltd. Pharmaceuticals: MajorHealth Technology Centus Biotherapeutics Ltd. is a British company that develops and manufactures biologic products. The joint venture company is based in Cambridge, UK. The company was founded in 2015.
3
| Joint Venture | Pharmaceuticals: Major | 3 |
Fujifilm Kyowa Kirin Biologics Co., Ltd.
 Fujifilm Kyowa Kirin Biologics Co., Ltd. BiotechnologyHealth Technology Fujifilm Kyowa Kirin Biologics Co., Ltd. develops and produces biopharmaceutical products and drugs. The joint venture company is based in Tokyo, Japan. It was founded in 2012, and the CEO is Yoshifumi Torii.
2
| Joint Venture | Biotechnology | 2 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Mitsuhiro Sato via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
Archigen Biotech Ltd.
 Archigen Biotech Ltd. Pharmaceuticals: MajorHealth Technology Archigen Biotech Ltd. is a British company that develops, manufactures, and distributes biological pharmaceuticals. Archigen Biotech is based in Cambridge, UK. The joint venture company was founded in 2014. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
| KYOWA KIRIN CO. LTD. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
CooperVision, Inc.
 CooperVision, Inc. Medical SpecialtiesHealth Technology CooperVision, Inc. engages in the manufacture of contact lenses. It offers monthly, two-week and daily disposable contact lenses, all featuring advanced materials and optics. The firm’s products include MyDay; clariti 1day , Biofinity , Proclear and Avaira family. The company was founded in 1950 and is headquartered in Victor, NY. | Medical Specialties | Corporate Officer/Principal | |
| NEXIMMUNE, INC. | Pharmaceuticals: Major | Director of Finance/CFO | |
Corvidia Therapeutics, Inc.
 Corvidia Therapeutics, Inc. BiotechnologyHealth Technology Corvidia Therapeutics, Inc. is a biotechnology company focusing on cardiovascular therapies. It develops treatments for atherosclerotic cardiovascular disease, inflammation in chronic kidney diseases, and high triglyceride-induced acute pancreatitis. The company was founded by Michael H. Davidson, Rahul Kakkar, Matt Devalaraja, and Ram Aiyar in 2015 and is headquartered in Waltham, MA. | Biotechnology | Director/Board Member | |
| Harvard Business School | College/University | Masters Business Admin | |
| Harvard College | College/University | Undergraduate Degree | |
AstraZeneca, Inc.
 AstraZeneca, Inc. BiotechnologyHealth Technology Part of AstraZeneca PLC, AstraZeneca, Inc. manufactures vaccines. | Biotechnology | Corporate Officer/Principal | |
| IMMUNOCORE HOLDINGS PLC | Biotechnology | Chief Operating Officer |
Statistieken
Internationaal
| Verenigde Staten | 7 |
| Verenigd Koninkrijk | 3 |
| Japan | 2 |
Sectoraal
| Health Technology | 8 |
| Consumer Services | 3 |
Operationeel
| Director/Board Member | 8 |
| Corporate Officer/Principal | 3 |
| Chief Executive Officer | 1 |
| President | 1 |
| Chief Tech/Sci/R&D Officer | 1 |
Sterkste connecties
| Insiders | |
|---|---|
| John Trainer | 8 |
| Yoshifumi Torii | 3 |
| Alex Wilkes | 3 |
| Karl David Bradshaw | 2 |
- Beurs
- Insiders
- Mitsuhiro Sato
- Bedrijfsconnecties
